International Society for Neonatal Screening

International Society for Neonatal Screening
Name	International Society for Neonatal Screening
Type	Professional association
Founded	1988
Headquarters	Leiden, Netherlands
Region served	Global
Leader title	President

Contents

International Society for Neonatal Screening is an international professional association dedicated to the promotion, development, and implementation of neonatal screening programs worldwide. The organization connects clinicians, researchers, public health officials, and policymakers from institutions such as World Health Organization, Centers for Disease Control and Prevention, European Commission, United Nations Children's Fund, and Bill & Melinda Gates Foundation. It fosters collaboration among stakeholders including Royal College of Paediatrics and Child Health, American Academy of Pediatrics, European Society for Paediatric Research, International Paediatric Association, and national agencies like Public Health England and Robert Koch Institute.

History

The society was established in 1988 amid growing international interest following landmark developments such as the expansion of newborn screening programs in United States, the introduction of tandem mass spectrometry techniques at laboratories like Mayo Clinic and Johns Hopkins Hospital, and policy debates influenced by reports from National Institutes of Health and panels convened by the European Commission. Founding members included representatives from Karolinska Institutet, University of Cambridge, Harvard Medical School, University of Toronto, and Erasmus University Rotterdam. Early activities paralleled initiatives by World Health Organization working groups and national advisory committees in Canada, Australia, Germany, and Japan, while scientific advances documented in journals associated with Nature and The Lancet shaped priorities. Over successive decades, the society adapted to breakthroughs from laboratories such as Centers for Disease Control and Prevention and consortia like the Human Genome Project and Global Alliance for Genomics and Health.

The society's mission emphasizes improving neonatal health by advancing screening methods, quality assurance, and policy harmonization across systems including those in United Kingdom, France, Sweden, China, India, and Brazil. Activities encompass guideline development influenced by committees from European Centre for Disease Prevention and Control, training programs aligned with curricula from Johns Hopkins Bloomberg School of Public Health and London School of Hygiene & Tropical Medicine, and support for laboratory networks modeled on standards from Clinical and Laboratory Standards Institute and accreditation bodies like International Organization for Standardization. It promotes technologies pioneered by teams at University of California, San Francisco, Massachusetts General Hospital, and Stanford University School of Medicine. The society also engages with regulatory institutions such as European Medicines Agency and Food and Drug Administration on implementation considerations.

Membership draws clinicians, scientists, policy experts, and laboratory directors affiliated with organizations like Royal College of Pathologists, American College of Medical Genetics and Genomics, Belgian Society of Pediatrics, Swiss Society for Pediatrics, and national ministries such as Ministry of Health (India), Ministry of Health and Welfare (Japan), and Ministry of Health (Brazil). Governance comprises an elected executive board, advisory committees, and regional representatives from continents represented by groups such as African Union, European Union, Organization of American States, and Association of Southeast Asian Nations. Elections and statutes reflect practices similar to those of International Committee of the Red Cross and Doctors Without Borders. The society partners with academic institutions like University of Sydney, McGill University, KU Leuven, and Charité – Universitätsmedizin Berlin for governance support and secretariat services.

The society organizes biennial international conferences hosted in cities including Leiden, Helsinki, Toronto, Tokyo, Melbourne, Amsterdam, and Lisbon. Conferences feature plenaries from experts at Harvard Medical School, panels with participants from World Health Organization, workshops led by staff from Centers for Disease Control and Prevention, and poster sessions showcasing work from laboratories at University of California, Los Angeles, University of Oxford, and Seoul National University. Proceedings often intersect with programs presented at meetings of European Society for Human Genetics, International Congress of Pediatrics, American Society of Human Genetics, and Society for Inherited Metabolic Disorders. The conferences facilitate collaboration with networks such as European Reference Networks and initiatives like Screen4Care.

Educational offerings include training modules co-developed with World Health Organization regional offices, e-learning hosted by University College London, and hands-on laboratory workshops modeled after curricula from Centers for Disease Control and Prevention newborn screening reference programs. Research priorities reflect collaborations with consortia such as Human Developmental Biology Resource, International Consortium on Newborn Screening, and university research centers at Johns Hopkins University, University of Pittsburgh, and University of North Carolina at Chapel Hill. The society issues consensus statements and technical guidelines informed by evidence synthesized from publications in The New England Journal of Medicine, BMJ, Nature Genetics, and reports from bodies like Institute of Medicine and National Academy of Medicine.

The society bestows awards recognizing contributions to screening science, program implementation, and advocacy, analogous to honors from Royal Society, Academy of Medical Sciences (UK), and Lasker Foundation. Past recipients have included investigators affiliated with Massachusetts Institute of Technology, Yale School of Medicine, University of Pennsylvania, University of Melbourne, and public health leaders from Centers for Disease Control and Prevention and Public Health Agency of Canada. Awards highlight achievements in laboratory innovation, policy development, and capacity building in low- and middle-income countries such as Nigeria, Kenya, Bangladesh, and Peru.

The society collaborates with stakeholders including World Health Organization, United Nations Children's Fund, Bill & Melinda Gates Foundation, European Commission, and national programs in Italy, Spain, Republic of Korea, and South Africa to influence newborn screening policy, funding, and implementation. Its work contributes to measurable public health outcomes through partnerships with screening laboratories at Mayo Clinic, surveillance systems like those operated by Centers for Disease Control and Prevention, and research networks including Global Alliance for Genomics and Health. The society’s guidance informs national matrices, capacity-building projects, and advocacy campaigns coordinated with organizations such as Save the Children, PATH, Clinton Health Access Initiative, and Gavi, the Vaccine Alliance, thereby shaping newborn screening expansion and equity worldwide.

Category:Neonatology organizations